ODDB.org: Open Drug Database

Spirig HealthCare AG - Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten

Swissmedic Registration	63119	Sequence	01
Product name	Ibandronat Spirig HC 150 mg Monatstabletten	Description	Filmtabletten
ATC-Classification	M05BA06	ATC-Description	Ibandronic Acid
Introduction of Sequence	26.03.2013

Composition

acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Ibandronic Acid	150 mg

BAG: Active Agent	Dose
Ibandronic Acid	150 mg

Inactive agents	Dose	additional_information



		Überzug
Hypromellosum
Macrogol	400
Polysorbatum 80
Povidone

Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		14.43	32.30	B	SL	No
004	3	41.91	62.50	B	SL	No

2025	©ywesee GmbH